|
1
|
Slattery ML, Potter JD, Samowitz W,
Schaffer D and Leppert M: Methylenetetrahydrofolate reductase, diet
and risk of colon cancer. Cancer Epidemiol Biomarkers Prev.
8:513–518. 1999.PubMed/NCBI
|
|
2
|
Frosst P, Blom HJ, Milos R, et al: A
candidate genetic risk factor for vascular disease: A common
mutation in methylenetetrahydrofolate reductase. Nat Genet.
10:111–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rozen R: Genetic predisposition to
hyperhomocysteinemia: Deficiency of methylenetetrahydrofolate
reductase (MTHFR). Thromb Haemost. 78:523–526. 1997.PubMed/NCBI
|
|
4
|
Kono S and Chen K: Genetic polymorphisms
of methylenetetrahydrofolate reductase and colorectal cancer and
adenoma. Cancer Sci. 96:535–542. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keku T, Millikan R, Worley K, Winkel S,
Eaton A, Biscocho L, Martin C and Sandler R:
5,10-Methylenetetrahydrofolate reductase codon 677 and 1298
polymorphisms and colon cancer in African Americans and whites.
Cancer Epidemiol Biomarkers Prev. 11:1611–1621. 2002.PubMed/NCBI
|
|
6
|
Kawakami K, Omura K, Kanehira E and
Watanabe Y: Polymorphic tandem repeats in the thymidylate synthase
gene is associated with its protein expression in human
gastrointestinal cancers. Anticancer Res. 19:3249–3252.
1999.PubMed/NCBI
|
|
7
|
Mandola MV, Stoehlmacher J, Zhang W,
Groshen S, Yu MC, Iqbal S, Lenz HJ and Ladner RD: A 6 bp
polymorphism in the thymidylate synthase gene causes message
instability and is associated with decreased intratumoral TS mRNA
levels. Pharmacogenetics. 14:319–327. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chango A, Emery-Fillon N, de Courcy GP,
Lambert D, Pfister M, Rosenblatt DS and Nicolas JP: A polymorphism
(80G->A) in the reduced folate carrier gene and its associations
with folate status and homocysteinemia. Mol Genet Metab.
70:310–315. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JW, Park HM, Choi YK, Chong SY, Oh D
and Kim NK: Polymorphisms in genes involved in folate metabolism
and plasma DNA methylation in colorectal cancer patients. Oncol
Rep. 25:167–172. 2011.PubMed/NCBI
|
|
10
|
Rah H, Choi YS, Jeon YJ, Choi Y, Cha SH,
Choi DH, Ko JJ, Shim SH and Kim NK: Solute Carrier Family 19,
member 1 (SLC19A1) polymorphisms (−43T>C, 80G>A and
696C>T) and haplotypes in idiopathic recurrent spontaneous
abortion in a Korean population. Reprod Sci. 19:513–519. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yim DJ, Kim OJ, An HJ, Kang H, Ahn DH,
Hwang SG, Oh D and Kim NK: Polymorphisms of thymidylate synthase
gene 5′- and 3′-untranslated region and risk of gastric cancer in
Koreans. Anticancer Res. 30:2325–2330. 2010.PubMed/NCBI
|
|
12
|
Chung YS, Jeon YJ, Shin DE, Min KT, Shin
YS, Won KS, Koh YC, Hong SH and Kim NK: Methylenetetrahydrofolate
reductase (MTHFR) and thymidylate synthase (TS) polymorphisms with
osteoporotic vertebral compression fracture (OVCF) in
postmenopausal Korean women. Genes Genom. 34:257–263. 2012.
View Article : Google Scholar
|
|
13
|
Sheng X, Zhang Y, Zhao E, Lu S, Zheng X,
Ge H and Lu W: MTHFR C677T polymorphism contributes to colorectal
cancer susceptibility: Evidence from 61 case-control studies. Mol
Biol Rep. 39:9669–9679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Z, Zhang XF, Liu HX, Hao YS and Zhao
CL: MTHFR C677T polymorphism and colorectal cancer risk in Asians,
a meta-analysis of 21 studies. Asian Pac J Cancer Prev.
13:1203–1208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Stampfer MJ, Giovannucci E, Artigas
C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen
R: Methylenetetrahydrofolate reductase polymorphism, dietary
interactions, and risk of colorectal cancer. Cancer Res.
57:1098–1102. 1997.PubMed/NCBI
|
|
16
|
van der Put NM, Gabreëls F, Stevens EM,
Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ:
A second common mutation in the methylenetetrahydrofolate reductase
gene: An additional risk factor for neural-tube defects? Am J Hum
Genet. 62:1044–1051. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawakami K and Watanabe G: Identification
and functional analysis of single nucleotide polymorphism in the
tandem repeat sequence of thymidylate synthase gene. Cancer Res.
63:6004–6007. 2003.PubMed/NCBI
|
|
18
|
Mandola MV, Stoehlmacher J, Muller-Weeks
S, Cesarone G, Yu MC, Lenz HJ and Ladner RD: A novel single
nucleotide polymorphism within the 5′tandem repeat polymorphism of
the thymidylate synthase gene abolishes USF-1 binding and alters
transcriptional activity. Cancer Res. 63:2898–2904. 2003.PubMed/NCBI
|
|
19
|
Zhou JY, Shi R, Yu HL, Zeng Y, Zheng WL
and Ma WL: The association between two polymorphisms in the TS gene
and risk of cancer: A systematic review and pooled analysis. Int J
Cancer. 131:2103–2116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Hunter DJ, Stampfer MJ, Kyte C,
Chan W, Wetmur JG, Mosig R, Selhub J and Ma J: Polymorphism in the
thymidylate synthase promoter enhancer region modifies the risk and
survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev.
12:958–962. 2003.PubMed/NCBI
|
|
21
|
Marsh S, Collie-Duguid ES, Li T, Liu X and
McLeod HL: Ethnic variation in the thymidylate synthase enhancer
region polymorphism among Caucasian and Asian populations.
Genomics. 58:310–312. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marsh S, McKay JA, Cassidy J and McLeod
HL: Polymorphism in the thymidylate synthase promoter enhancer
region in colorectal cancer. Int J Oncol. 19:383–386.
2001.PubMed/NCBI
|
|
23
|
Ulrich CM, Curtin K, Potter JD, Bigler J,
Caan B and Slattery ML: Polymorphisms in the reduced folate
carrier, thymidylate synthase, or methionine synthase and risk of
colon cancer. Cancer Epidemiol Biomarkers Prev. 14:2509–2516. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Jonge R, Tissing WJ, Hooijberg JH,
Jansen G, Kaspers GJ, Lindemans J, Peters GJ and Pieters R:
Polymorphisms in folate-related genes and risk of pediatric acute
lymphoblastic leukemia. Blood. 113:2284–2289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Chen W, Wang J, Tan Y, Zhou Y,
Ding W, Hua Z, Shen J, Xu Y and Shen H: Reduced folate carrier gene
G80A polymorphism is associated with an increased risk of
gastroesophageal cancers in a Chinese population. Eur J Cancer.
42:3206–3211. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eklöf V, Van Guelpen B, Hultdin J,
Johansson I, Hallmans G and Palmqvist R: The reduced folate carrier
(RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T
polymorphisms and the risk of colorectal cancer: A nested
case-referent study. Scand J Clin Lab Invest. 68:393–401. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jokić M, Brčić-Kostić K, Stefulj J, Catela
Ivković T, Božo L, Gamulin M and Kapitanović S: Association of
MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with
susceptibility to sporadic colon cancer. DNA Cell Biol. 30:771–776.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Antony AC: The biological chemistry of
folate receptors. Blood. 79:2807–2820. 1992.PubMed/NCBI
|
|
29
|
Duthie SJ: Folate and cancer: How DNA
damage, repair and methylation impact on colon carcinogenesis. J
Inherit Metab Dis. 34:101–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giovannucci E: Metabolic syndrome,
hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr.
86:s836–s842. 2007.PubMed/NCBI
|
